Finance

Lists
Why is TMCI up 2,05%?
Dive Deeper
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,48 $
+2,05%
(+0,090) 1D
5 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TMCI...
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
146,38 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
146,38 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc
CEO-
Employees450
Founded2014
Headquarters-
Sector-
Websitetreace.com
Analyst ratings
Based on 3 analysts giving stock ratings to TMCI in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TMCI in the last 3 months.
Highest
Current 4,48 $
7,00 $ (+56,25%)
Average
5,50 $ (+22,77%)
Lowest
4,50 $ (+0,45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Hold
Maintained
4,50 $
+0,4%
08/11/2026
Ben Haynor
Lake Street
Buy
Reiterated
7,00 $
+56,2%
08/10/2026
Richard Newitter
Truist Financial
Hold
Reiterated
5,00 $
+11,6%
08/10/2026
Danielle Antalffy
UBS
Hold
Maintained
2,25 $
-49,8%
03/02/2026
Last report
07 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,20 $ / -0,30 $
+33,30%beat
Revenue / Est. (USD)
45,38 մլն / 43,92 մլն
+3,30%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
50,21 մլն
62,52 մլն
47,20 մլն
45,38 մլն
Cost of goods sold
10,51 մլն
12,12 մլն
9,79 մլն
9,77 մլն
Cost of revenue
10,51 մլն
12,12 մլն
9,79 մլն
9,77 մլն
Research and development expenses
4,68 մլն
4,54 մլն
4,62 մլն
4,38 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49,70 մլն
51,78 մլն
49,95 մլն
46,19 մլն
Operating expense
54,38 մլն
56,32 մլն
54,57 մլն
50,56 մլն
Total operating expenses
64,89 մլն
68,44 մլն
64,36 մլն
60,33 մլն
Operating income
-14,68 մլն
-5,92 մլն
-17,17 մլն
-14,96 մլն
Other non operating income
92,00 հզր
88,00 հզր
275,00 հզր
202,00 հզր
EBT including unusual items
-16,29 մլն
-9,39 մլն
-17,96 մլն
-15,87 մլն
EBT excluding unusual items
-15,29 մլն
-6,66 մլն
-17,96 մլն
-15,87 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,29 մլն
-9,39 մլն
-17,96 մլն
-15,87 մլն
Net profit margin
-32,44%
-15,03%
-38,05%
-34,98%
Earnings per share
-0,22
-0,08
-0,12
-0,20
Interest and investment income
634,00 հզր
527,00 հզր
501,00 հզր
445,00 հզր
Interest expense
-1,34 մլն
-1,35 մլն
-1,57 մլն
-1,56 մլն
Net interest expenses
-704,00 հզր
-823,00 հզր
-1,07 մլն
-1,12 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,90 մլն
-4,11 մլն
-16,27 մլն
-13,07 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps